Professor Gordon Cook
MB ChB, PhD, FRCP(Glas), FRCPath.
Professor of Haematology & Myeloma Studies, Honorary Consultant Haematologist
Clinical Director (haematology) CTRU
Experimental Haematology, Leeds Institute of Cancer & Pathology, University of Leeds. Leeds Cancer Centre, Leeds Teaching Hospitals Trust, Leeds
Professor Cook is a graduate of the University of Glasgow School of Medicine and received his higher professional training in haematology in the West of Scotland. After completion of his PhD, he was appointed as a Consultant Haematologist in the West of Scotland before moving to take up the post of Director of Stem Cell Transplantation at Leeds Teaching Hospitals in 2002. In 2013 he was appointed as Professor of Haematology, University of Leeds where he leads the myeloma clinical and translational research portfolio with a primary interest in tumour immunology and immunotherapy.
Professor Cook is Chair of the UK Myeloma Research Alliance and NCRI Myeloma sub-group as well as a member of the NCRI Haematology-Oncology Clinical Studies Group. He is the chair of the UK Myeloma Forum and have represented the interests of both myeloma clinicians and patients in NICE reviews.
I am Chief Investigator for NCRI Myeloma X (completed), UKMRA Myeloma XII (in recruitment), UKMRA Myeloma XIV (in set-up), MUKeight (in recruitment) and MUKeleven (in recruitment). My collaboration with industry includes my position as the UK Chief investigator for 4 industry international phase III and IIIb studies & I am the chair of the Myeloma UK Research Advisory Group and Medical Editor of Myeloma Today. Finally I hold the posts of Clinical Director of NIHR Leeds In Vitro Diagnostics Co-operative and Clinical Director (Haematology), CTRU, University of Leeds.